Skip to main navigation Skip to search Skip to main content

Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization

  • J. J. Patten
  • , Patrick T. Keiser
  • , Deisy Morselli-Gysi
  • , Giulia Menichetti
  • , Hiroyuki Mori
  • , Callie J. Donahue
  • , Xiao Gan
  • , Italo do Valle
  • , Kathleen Geoghegan-Barek
  • , Manu Anantpadma
  • , Ruth Mabel Boytz
  • , Jacob L. Berrigan
  • , Sarah H. Stubbs
  • , Tess Ayazika
  • , Colin O'Leary
  • , Sallieu Jalloh
  • , Florence Wagner
  • , Seyoum Ayehunie
  • , Stephen J. Elledge
  • , Deborah Anderson
    • Joseph Loscalzo, Marinka Zitnik, Suryaram Gummuluru, Mark N. Namchuk, Albert László Barabási, Robert A. Davey*
*Corresponding author for this work
  • Boston University
  • Northeastern University
  • Harvard University
  • Howard Hughes Medical Institute
  • Broad Institute
  • MatTek Corporation

Research output: Contribution to journal › Article › peer-review

Search results